High-dose, variable-length, intravenous N-acetylcysteine (HINAC) therapy for acetaminophen poisoning

被引：0
作者：
Moore, Philip W. [3 ]
Donovan, J. Ward [3 ]
Burkhart, Keith K. [1 ]
Daniello, Todd C. [2 ]
Smith, Erin Mancuso [4 ]
Andharia, Neel [3 ]
Dorai, Suprina [5 ]
Eygnor, Jessica [5 ]
Wirt, Yijin [3 ]
机构：
[1] US FDA, Rockville, MD 20857 USA
[2] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA
[3] PinnacleHlth Syst, Harrisburg, PA USA
[4] Novant Hlth Presbyterian Med Ctr, Charlotte, NC USA
[5] Lehigh Valley Hlth Network, Lehigh Valley, PA USA
来源：
CLINICAL TOXICOLOGY | 2013年 / 51卷 / 07期
关键词：
Acetaminophen (paracetamol); N-acetylcysteine; Hepatotoxicity;
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
14
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [31] Antiemetic use in acetaminophen poisoning: how does the route of N-acetylcysteine administration affect utilization?
    Miller M.A.
    Navarro M.
    Bird S.B.
    Donovan J.L.
    Journal of Medical Toxicology, 2007, 3 (4) : 152 - 156
  • [32] Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin C?
    Erturk, Mehmet
    Uslu, Nevzat
    Gorgulu, Sevket
    Akbay, Ertan
    Kurtulus, Gulsah
    Akturk, Ibrahim F.
    Akgul, Ozgur
    Surgit, Ozgur
    Uzun, Fatih
    Gul, Mehmet
    Isiksacan, Nilgun
    Yildirim, Aydin
    CORONARY ARTERY DISEASE, 2014, 25 (02) : 111 - 117
  • [33] A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis
    N Dauletbaev
    P Fischer
    B Aulbach
    J Gross
    W Kusche
    U Thyroff-Friesinger
    TOF Wagner
    J Bargon
    European Journal of Medical Research, 14 (8)
  • [34] Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patients
    De Backer, Jan
    Vos, Wim
    Van Holsbeke, Cedric
    Vinchurkar, Samir
    Claes, Rita
    Parizel, Paul M.
    De Backer, Wilfried
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 8 : 569 - 579
  • [35] High-risk acetaminophen overdose outcomes after treatment with standard dose vs. increased dose N-acetylcysteine
    Moss, Michael
    Hinchman, Brynne
    Lambson, Joseph
    Rhein, Taylor
    Scott, Julie
    Hinckley, Paul
    Wylie, Sawyer
    Dorey, Alyrene
    CLINICAL TOXICOLOGY, 2023, 61 : 64 - 64
  • [36] High-dose Intravenous N-Acetylcysteine in Mechanically Ventilated Patients with COVID-19 Pneumonia: A Propensity-Score Matched Cohort Study
    Fong, Ka Man
    Ng, George Wing Yiu
    Leung, Anne Kit Hung
    Lai, Kang Yiu
    JOURNAL OF INTENSIVE CARE MEDICINE, 2024,
  • [37] Evaluation of the efficacy of high-dose n-acetylcysteine in preventing contrast-induced nephropathy in the emergency department
    Aydin, Omerul Faruk
    Guneysel, Ozlem
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2025, 16 (02): : 127 - 132
  • [38] Comparison of low-risk and high-risk acetaminophen ingestions using the standard prescott protocol of intravenous N-acetylcysteine
    Ulici, Alexandru
    Cole, Jon
    Olives, Travis
    Lange, Rebecca
    Bangh, Stacey
    CLINICAL TOXICOLOGY, 2023, 61 : 64 - 64
  • [39] Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients
    Haase, Michael
    Haase-Fielitz, Anja
    Bagshaw, Sean M.
    Reade, Michael C.
    Morgera, Stanislao
    Seevenayagam, Siven
    Matalanis, George
    Buxton, Brian
    Doolan, Laurie
    Bellomo, Rinaldo
    CRITICAL CARE MEDICINE, 2007, 35 (05) : 1324 - 1331
  • [40] Assessing the frequency and types of errors involved in the use of a modified intravenous N-acetylcysteine protocol for acetaminophen overdose
    J. Ali
    M. Thompson
    Connie Mackenzie
    Canadian Journal of Emergency Medicine, 2024, 26 : 174 - 178
12345